Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2005 Filed Mar 17, 2005 01:19 UTC |
PELHAM JUDITH CDirector
|
GrantNQSO(Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017376 · rrd72869.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-03-15 Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 01:19 UTC |
PELHAM JUDITH CDirector
|
GrantRestricted Stock Units | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-017376 · rrd72869.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 F1 · security: (DIR 03.15.05) The Restriced Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 01:25 UTC |
RICE DONALD BDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017377 · rrd72868.xml · derivative · entry 3 RICE DONALD B · CIK 0001183516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-03-15 Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 01:25 UTC |
RICE DONALD BDirector
|
GrantRestricted Stock Units | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-017377 · rrd72868.xml · nonDerivative · entry 2 RICE DONALD B · CIK 0001183516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 01:41 UTC |
BALTIMORE DAVIDDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017379 · rrd72836.xml · derivative · entry 3 BALTIMORE DAVID · CIK 0001185858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-03-15 Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 01:41 UTC |
BALTIMORE DAVIDDirector
|
GrantRestricted Stock Units | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-017379 · rrd72836.xml · nonDerivative · entry 2 BALTIMORE DAVID · CIK 0001185858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 18:03 UTC |
BIONDI FRANKDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017449 · rrd72829.xml · derivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-03-15 Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 18:03 UTC |
BIONDI FRANKDirector
|
GrantRestricted Stock Units | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-017449 · rrd72829.xml · nonDerivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,349 F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to be Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 19:55 UTC |
SCHAEFFER LEONARD DDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017488 · rrd72880.xml · derivative · entry 2 SCHAEFFER LEONARD D · CIK 0001016369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-03-15 Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 19:55 UTC |
SCHAEFFER LEONARD DDirector
|
GrantRestricted Stock Units | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-017488 · rrd72880.xml · nonDerivative · entry 1 SCHAEFFER LEONARD D · CIK 0001016369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,349 F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 19:56 UTC |
REASON J PAULDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017489 · rrd72842.xml · derivative · entry 3 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-03-15 Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 19:56 UTC |
REASON J PAULDirector
|
GrantRestricted Stock Units | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-017489 · rrd72842.xml · nonDerivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 F1 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2005 Filed Apr 12, 2005 00:10 UTC |
FRITZKY EDWARD VDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-021702 · rrd74726.xml · derivative · entry 6 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-03-15 Read SEC document |
| March 15, 2005 Filed Apr 12, 2005 00:10 UTC |
FRITZKY EDWARD VDirector
|
GrantRestricted Stock Units | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-021702 · rrd74726.xml · nonDerivative · entry 5 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 F2 · security: (DIR 03.15.05) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise differed by the director. Read SEC document |
| March 07, 2005 Filed Mar 8, 2005 18:17 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 30,000 | $62.04 | $1,861,077.00 |
DisclosureSEC source: 0001181431-05-015244 · rrd71671.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 976,627 Read SEC document |
| March 07, 2005 Filed Mar 8, 2005 18:17 UTC |
OMENN GILBERT SDirector
|
SaleCommon Stock | 500 | $62.59 | $31,295.00 |
DisclosureSEC source: 0001181431-05-015245 · rrd71678.xml · nonDerivative · entry 3 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,011 F1 · balance_after: (GSO 2.05) Does not include (i) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (ii) 5,590 shares held indirectly by the reporting person's son. Read SEC document |
| March 07, 2005 Filed Mar 8, 2005 18:17 UTC |
OMENN GILBERT SDirector
|
SaleCommon Stock | 500 | $62.52 | $31,260.00 |
DisclosureSEC source: 0001181431-05-015245 · rrd71678.xml · nonDerivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,511 F1 · balance_after: (GSO 2.05) Does not include (i) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (ii) 5,590 shares held indirectly by the reporting person's son. Read SEC document |
| March 07, 2005 Filed Mar 8, 2005 18:17 UTC |
OMENN GILBERT SDirector
|
SaleCommon Stock | 1,000 | $62.50 | $62,500.00 |
DisclosureSEC source: 0001181431-05-015245 · rrd71678.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,011 F1 · balance_after: (GSO 2.05) Does not include (i) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (ii) 5,590 shares held indirectly by the reporting person's son. Read SEC document |
| March 07, 2005 Filed Mar 8, 2005 18:17 UTC |
BONANNI FABRIZIOSenior VP, Manufacturing
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $39.03 | $0.00 |
DisclosureSEC source: 0001181431-05-015246 · rrd71753.xml · derivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,190 Underlying: Common Stock · 30,000 shares Expires 2006-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2005 Filed Mar 8, 2005 18:17 UTC |
BONANNI FABRIZIOSenior VP, Manufacturing
|
SaleCommon Stock | 30,000 | $62.08 | $1,862,463.00 |
DisclosureSEC source: 0001181431-05-015246 · rrd71753.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,530 F1 · balance_after: (FB 3.07.05) Does not include 6,901 shares indirectly held by the family trust. Read SEC document |
| March 07, 2005 Filed Mar 8, 2005 18:17 UTC |
BONANNI FABRIZIOSenior VP, Manufacturing
|
Exercise / conversionCommon Stock | 30,000 | $39.03 | $1,170,939.00 |
DisclosureSEC source: 0001181431-05-015246 · rrd71753.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (FB 3.07.05) Does not include 6,901 shares indirectly held by the family trust. Read SEC document |
| February 23, 2005 Filed Feb 24, 2005 21:54 UTC |
SCOTT DAVID JSr. VP, Gen. Counsel & Secy.
|
Tax withholdingCommon Stock | 2,239 | $61.34 | $137,340.26 |
DisclosureSEC source: 0001181431-05-012411 · rrd70214.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,761 Read SEC document |
| February 17, 2005 Filed Mar 8, 2005 18:17 UTC |
JOHNSON FRANKLIN P JRDirector
|
GiftCommon Stock | 362,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-015244 · rrd71671.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,006,627 F1 · kind: (FPJ 3.07.05) Shares are being transferred to the Johnson Revocable Trust dated June 25, 2003. Read SEC document |
| February 17, 2005 Filed Mar 8, 2005 18:17 UTC |
JOHNSON FRANKLIN P JRDirector
|
GiftCommon Stock | 178,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-015244 · rrd71671.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 F1 · kind: (FPJ 3.07.05) Shares are being transferred to the Johnson Revocable Trust dated June 25, 2003. Read SEC document |
| February 17, 2005 Filed Mar 8, 2005 18:17 UTC |
JOHNSON FRANKLIN P JRDirector
|
GiftCommon Stock | 183,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-015244 · rrd71671.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712,043 F1 · kind: (FPJ 3.07.05) Shares are being transferred to the Johnson Revocable Trust dated June 25, 2003. F2 · balance_after: (FPJ 3.07.05) Does not include (i) 4 units contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (ii) 600,000 shares held as indirect ownership by the Partnership. The reporting person disclaims beneficial ownership of the securities held by the Partnership and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| February 11, 2005 Filed Feb 14, 2005 21:25 UTC |
OMENN GILBERT SDirector
|
SaleCommon Stock | 1,000 | $63.27 | $63,270.00 |
DisclosureSEC source: 0001181431-05-009551 · rrd68512.xml · nonDerivative · entry 6 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,011 F1 · balance_after: (GSO 2.05) Does not include (i) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (ii) 5,590 shares held indirectly by the reporting person's son. Read SEC document |
| February 11, 2005 Filed Feb 14, 2005 21:25 UTC |
OMENN GILBERT SDirector
|
SaleCommon Stock | 1,000 | $63.31 | $63,310.00 |
DisclosureSEC source: 0001181431-05-009551 · rrd68512.xml · nonDerivative · entry 5 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,011 F1 · balance_after: (GSO 2.05) Does not include (i) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (ii) 5,590 shares held indirectly by the reporting person's son. Read SEC document |
| February 11, 2005 Filed Feb 14, 2005 21:25 UTC |
OMENN GILBERT SDirector
|
SaleCommon Stock | 1,000 | $63.41 | $63,410.00 |
DisclosureSEC source: 0001181431-05-009551 · rrd68512.xml · nonDerivative · entry 4 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,011 F1 · balance_after: (GSO 2.05) Does not include (i) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (ii) 5,590 shares held indirectly by the reporting person's son. Read SEC document |
| February 11, 2005 Filed Feb 14, 2005 21:25 UTC |
OMENN GILBERT SDirector
|
SaleCommon Stock | 1,000 | $63.57 | $63,570.00 |
DisclosureSEC source: 0001181431-05-009551 · rrd68512.xml · nonDerivative · entry 3 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,011 F1 · balance_after: (GSO 2.05) Does not include (i) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (ii) 5,590 shares held indirectly by the reporting person's son. Read SEC document |
| February 11, 2005 Filed Feb 14, 2005 21:25 UTC |
OMENN GILBERT SDirector
|
SaleCommon Stock | 1,000 | $63.90 | $63,900.00 |
DisclosureSEC source: 0001181431-05-009551 · rrd68512.xml · nonDerivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,011 F1 · balance_after: (GSO 2.05) Does not include (i) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (ii) 5,590 shares held indirectly by the reporting person's son. Read SEC document |
| February 11, 2005 Filed Feb 14, 2005 21:25 UTC |
OMENN GILBERT SDirector
|
SaleCommon Stock | 2,000 | $63.15 | $126,300.00 |
DisclosureSEC source: 0001181431-05-009551 · rrd68512.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,011 F1 · balance_after: (GSO 2.05) Does not include (i) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (ii) 5,590 shares held indirectly by the reporting person's son. Read SEC document |
| February 10, 2005 Filed Feb 16, 2005 21:27 UTC |
SHARER KEVIN WDirector · Chairman of the Bd.CEO & Pres
|
GiftCommon Stock | 19,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-010462 · rrd68738.xml · nonDerivative · entry 4 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Indirect · Living Trust Disclosed balance after: 33,091 F2 · kind: (KWS 2.10.05) These shares previously reported as being indirectly held by the reporting person's family trust is being transferred to the reporting person's living trust. F3 · balance_after: (KWS 2.14.05) The amount of the Company's Common Stock beneficially owned has been adjusted to reflect an acquisition by the reporting person of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and subsequent transfer of such shares to reporting person's living trust. Read SEC document |
| February 10, 2005 Filed Feb 16, 2005 21:27 UTC |
SHARER KEVIN WDirector · Chairman of the Bd.CEO & Pres
|
GiftCommon Stock | 13,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-010462 · rrd68738.xml · nonDerivative · entry 3 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Indirect · Living Trust Disclosed balance after: 13,789 F1 · kind: (KWS 2.05) These shares previously reported as being directly held by the reporting person is being transferred to the reporting person's living trust. F3 · balance_after: (KWS 2.14.05) The amount of the Company's Common Stock beneficially owned has been adjusted to reflect an acquisition by the reporting person of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and subsequent transfer of such shares to reporting person's living trust. Read SEC document |
| February 10, 2005 Filed Feb 16, 2005 21:27 UTC |
SHARER KEVIN WDirector · Chairman of the Bd.CEO & Pres
|
GiftCommon Stock | 19,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-010462 · rrd68738.xml · nonDerivative · entry 2 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 F2 · kind: (KWS 2.10.05) These shares previously reported as being indirectly held by the reporting person's family trust is being transferred to the reporting person's living trust. Read SEC document |
| February 10, 2005 Filed Feb 16, 2005 21:27 UTC |
SHARER KEVIN WDirector · Chairman of the Bd.CEO & Pres
|
GiftCommon Stock | 13,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-010462 · rrd68738.xml · nonDerivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd.CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: (KWS 2.05) These shares previously reported as being directly held by the reporting person is being transferred to the reporting person's living trust. Read SEC document |
| February 04, 2005 Filed Feb 7, 2005 17:33 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 27,896 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-05-007442 · rrd67512.xml · derivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 27,896 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2005 Filed Feb 7, 2005 17:33 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
SaleCommon Stock | 27,896 | $62.57 | $1,745,494.56 |
DisclosureSEC source: 0001181431-05-007442 · rrd67512.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,587 F1 · balance_after: (DMF 1/05) Does not include (i) 20,000 shares of Amgen Inc. Common Stock directly held by the reporting person and (ii) 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| February 04, 2005 Filed Feb 7, 2005 17:33 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
Exercise / conversionCommon Stock | 27,896 | $16.38 | $456,797.00 |
DisclosureSEC source: 0001181431-05-007442 · rrd67512.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 135,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 1/05) Does not include (i) 20,000 shares of Amgen Inc. Common Stock directly held by the reporting person and (ii) 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| February 04, 2005 Filed Feb 7, 2005 19:20 UTC |
JOHNSON FRANKLIN P JRDirector
|
GiftCommon Stock | 2,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-007489 · rrd67514.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 895,782 F1 · balance_after: (FPJ 2.04.05) Does not include (i) 4 units contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., (ii) 600,000 shares held as indirect ownership by the Partnership, and (iii) 822,888 shares held as indirect ownership by reporting person's spouse. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| February 03, 2005 Filed Feb 4, 2005 18:42 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $62.43 | $624,300.00 |
DisclosureSEC source: 0001181431-05-007195 · rrd67361.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 600,000 F1 · balance_after: (FPJ 2.03.05) Does not include (i) 898,622 shares held directly by the reporting person, (ii) 4 units contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 822,888 Shares held as indirect ownership by reporting person's spouse. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| February 03, 2005 Filed Feb 4, 2005 18:42 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 9,400 | $62.42 | $586,748.00 |
DisclosureSEC source: 0001181431-05-007195 · rrd67361.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 610,000 F1 · balance_after: (FPJ 2.03.05) Does not include (i) 898,622 shares held directly by the reporting person, (ii) 4 units contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 822,888 Shares held as indirect ownership by reporting person's spouse. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| February 03, 2005 Filed Feb 4, 2005 18:42 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 7,500 | $62.05 | $465,375.00 |
DisclosureSEC source: 0001181431-05-007195 · rrd67361.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 619,400 F1 · balance_after: (FPJ 2.03.05) Does not include (i) 898,622 shares held directly by the reporting person, (ii) 4 units contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 822,888 Shares held as indirect ownership by reporting person's spouse. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| February 03, 2005 Filed Feb 4, 2005 18:42 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 7,500 | $62.00 | $465,000.00 |
DisclosureSEC source: 0001181431-05-007195 · rrd67361.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 626,900 F1 · balance_after: (FPJ 2.03.05) Does not include (i) 898,622 shares held directly by the reporting person, (ii) 4 units contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 822,888 Shares held as indirect ownership by reporting person's spouse. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 208,000 | $0.00 Strike: $57.94 | $0.00 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · derivative · entry 12 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 204,340 shares Expires 2011-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 25,000 | $62.52 | $1,563,002.50 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 11 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,225 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 10,000 | $62.29 | $622,875.00 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 10 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,225 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 15,000 | $62.34 | $935,151.00 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 9 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,225 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 25,000 | $62.30 | $1,557,500.00 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 8 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,225 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 25,000 | $62.42 | $1,560,582.50 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 7 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,225 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 25,000 | $62.42 | $1,560,465.00 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 6 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,225 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.